Thank you, Mr. Chair. We don't as much negotiate the formulary as provide input, sort of trend data that helps inform the NIHB in them developing the formulary, so it's not really a matter of negotiation. It is their formulary. We run the program on their behalf, or we administer the program on their behalf. Data that we gather in terms of both utilization and also demand for certain drugs and so on that are in demand can help the program determine what should go on the formulary next, but I think, if I'm not mistaken, I believe the NIHB are actually aligned with the Ontario formulary, so the real work on that list takes place out of Ottawa and in line with the Ontario approach.
Mr. Cooper on Consideration in Committee of the Whole of Bills and Other Matters
In the Legislative Assembly on March 1st, 2018. See this statement in context.
Consideration in Committee of the Whole of Bills and Other Matters
Consideration in Committee of the Whole of Bills and Other Matters
February 28th, 2018
Cooper
See context to find out what was said next.